NexGel, Inc. (NASDAQ:NXGL – Free Report) – Maxim Group issued their Q3 2026 EPS estimates for shares of NexGel in a note issued to investors on Tuesday, September 29th. Maxim Group analyst N. Rahman expects that the company will earn ($0.24) per share for the quarter. Maxim Group currently has a “Hold” rating on the stock. The consensus estimate for NexGel’s current full-year earnings is ($0.94) per share. Maxim Group also issued estimates for NexGel’s Q4 2026 earnings at ($0.20) EPS, FY2026 earnings at ($0.94) EPS and FY2027 earnings at ($0.22) EPS.
NexGel (NASDAQ:NXGL – Get Free Report) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.28). NexGel had a negative net margin of 51.26% and a negative return on equity of 121.18%. The company had revenue of $3.69 million during the quarter, compared to the consensus estimate of $4.32 million.
View Our Latest Analysis on NexGel
NexGel Stock Performance
NASDAQ:NXGL opened at $0.17 on Monday. The stock has a fifty day moving average price of $0.32 and a 200-day moving average price of $0.49. The company has a market cap of $1.69 million, a price-to-earnings ratio of -0.24 and a beta of 0.82. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.27 and a current ratio of 0.43. NexGel has a fifty-two week low of $0.16 and a fifty-two week high of $2.89.
Hedge Funds Weigh In On NexGel
A hedge fund recently bought a new stake in NexGel stock. Board of Trustees of The Leland Stanford Junior University bought a new stake in NexGel, Inc. (NASDAQ:NXGL – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 32,500 shares of the company’s stock, valued at approximately $52,000. NexGel makes up approximately 0.0% of Board of Trustees of The Leland Stanford Junior University’s holdings, making the stock its 19th largest holding. Board of Trustees of The Leland Stanford Junior University owned approximately 0.40% of NexGel at the end of the most recent quarter. Institutional investors and hedge funds own 2.21% of the company’s stock.
About NexGel
NexGel, Inc develops and manufactures high-water-content, electron-beam-crosslinked aqueous polymer hydrogels. Its products are designed to provide electrical conductivity, moisture retention, cushioning, and cooling for a range of medical, consumer, and industrial applications.
The company’s hydrogel products are used in medical electrodes for applications such as electrocardiography, neuromuscular stimulation, and defibrillation, as well as in ultrasound procedures. NexGel also supplies nonconductive hydrogels for wound care, burn care, scar treatment, and cosmetic products, along with specialized formulations for veterinary and other commercial uses.
Based in Langhorne, Pennsylvania, NexGel serves customers through business-to-business relationships with medical-device manufacturers and other product companies.
Featured Articles
- Five stocks we like better than NexGel
- Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AI
- Lamb Weston’s Turnaround Is Starting to Look Real
- These 3 Stocks Got the Most Love From Analysts in September
- Record French Debt Could Create Opportunities for U.S. Market Operators
Receive News & Ratings for NexGel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexGel and related companies with MarketBeat.com's FREE daily email newsletter.
